First Trust Advisors LP Sells 32,742 Shares of The Cooper Companies, Inc. $COO

Posted by on Aug 2nd, 2026

First Trust Advisors LP cut its position in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 21.4% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 120,148 shares of the medical device company’s stock after selling 32,742 shares during the period. First Trust Advisors LP’s holdings in Cooper Companies were worth $8,591,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in COO. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Cooper Companies by 48.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock valued at $1,890,000 after purchasing an additional 7,363 shares during the period. Cresset Asset Management LLC purchased a new position in Cooper Companies during the 2nd quarter worth $291,000. Cerity Partners LLC increased its holdings in Cooper Companies by 4.4% during the 2nd quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock worth $1,272,000 after purchasing an additional 757 shares during the period. Daiwa Securities Group Inc. raised its position in Cooper Companies by 2.8% during the 2nd quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock valued at $2,551,000 after purchasing an additional 973 shares in the last quarter. Finally, State Street Corp raised its position in Cooper Companies by 1.2% during the 2nd quarter. State Street Corp now owns 8,659,741 shares of the medical device company’s stock valued at $616,227,000 after purchasing an additional 104,910 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Stock Performance

COO opened at $72.32 on Friday. The Cooper Companies, Inc. has a 52-week low of $58.89 and a 52-week high of $89.83. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The company has a market cap of $14.10 billion, a P/E ratio of 61.29, a price-to-earnings-growth ratio of 1.89 and a beta of 0.84. The firm’s 50-day moving average price is $68.36 and its 200-day moving average price is $71.79.

Cooper Companies (NASDAQ:COO – Get Free Report) last released its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.11. The firm had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm’s revenue was up 7.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, equities analysts anticipate that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts recently weighed in on COO shares. JPMorgan Chase & Co. lowered their price objective on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research note on Friday, June 5th. UBS Group initiated coverage on shares of Cooper Companies in a research report on Tuesday, July 28th. They set a “neutral” rating and a $75.00 target price on the stock. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a report on Sunday, June 21st. KeyCorp reaffirmed a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. Finally, The Goldman Sachs Group set a $61.00 price objective on shares of Cooper Companies in a research note on Wednesday, May 27th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $81.36.

Check Out Our Latest Stock Analysis on COO

About Cooper Companies

(Free Report)

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

Read More

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.